CYAD

Celyad Oncology S.A.

Healthcare

Set alert

Price alert · CYAD

All alert types
0.47 0.00 0.00%
As of May 18, 2023
0.47 Day range 0.528

52-week range unavailable

Open
0.52
Prev close
0.47
Mkt cap
14.24M
Vol
49.00K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.47
High
0.528
Forward P/E
-0.11
Beta
1.69
Short ratio
11.46
Inst. own
29.15%
Dividend
0.00
Ex-div date
Earnings
Mar 23, 2023
50-d avg
0.662867
200-d avg
1.07
1y target
8.52

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CYAD has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-39.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.2×
FY 2015: -14.7×FY 2016: -6.7×FY 2017: -5.9×FY 2018: -4.9×FY 2019: -4.1×FY 2020: -5.1×FY 2021: -1.9×FY 2022: -0.3×FY 2023: -1.3×FY 2024: -3.2×
FY 2015 5y median -1.9× FY 2024
P/S 101×
FY 2015: 142120×FY 2016: 15.7×FY 2017: 93.8×FY 2018: 56.6×FY 2019: 19393×FY 2020: 17795×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 107×FY 2024: 101×
FY 2015 5y median 101× FY 2024
P/B 0.0×
FY 2015: 3.8×FY 2016: 1.7×FY 2017: 7.0×FY 2018: 3.2×FY 2019: 2.6×FY 2020: 2.9×FY 2021: 1.2×FY 2022: 2.4×FY 2023: 1.7×FY 2024: 0.0×
FY 2015 5y median 1.7× FY 2024
P/FCF 0.0×
FY 2015: -15.2×FY 2016: -5.9×FY 2017: -6.6×FY 2018: -6.1×FY 2019: -4.0×FY 2020: -3.2×FY 2021: -1.9×FY 2022: -0.4×FY 2023: -0.7×FY 2024: 0.0×
FY 2015 5y median -0.7× FY 2024
EV/EBITDA 0.0×
FY 2015: -11.6×FY 2016: -5.0×FY 2017: -6.6×FY 2018: -3.8×FY 2019: -3.1×FY 2020: -5.0×FY 2021: -0.9×FY 2022: 0.0×FY 2023: -0.6×FY 2024: 0.0×
FY 2015 5y median -0.6× FY 2024
EV/Sales 0.0×
FY 2015: 108953×FY 2016: 11.0×FY 2017: 87.6×FY 2018: 44.1×FY 2019: 13564×FY 2020: 15076×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 48.9×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024
FCF Yield 0.0%
FY 2015: -6.6%FY 2016: -16.9%FY 2017: -15.2%FY 2018: -16.4%FY 2019: -24.8%FY 2020: -31.5%FY 2021: -53.8%FY 2022: -270.5%FY 2023: -147.2%FY 2024: 0.0%
FY 2015 5y median -53.8% FY 2024

Profitability

Gross Margin 93.5%
FY 2015: 33.3%FY 2016: 84.6%FY 2017: 85.5%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 32.4%FY 2024: 93.5%
FY 2015 5y median 32.4% FY 2024
Operating Margin -3149.5%
FY 2015: -989066.7%FY 2016: -255.8%FY 2017: -1493.7%FY 2018: -1225.4%FY 2019: -481316.7%FY 2020: -339740.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -8291.2%FY 2024: -3149.5%
FY 2015 5y median -3149.5% FY 2024
Net Margin -3131.2%
FY 2015: -970466.7%FY 2016: -235.8%FY 2017: -1593.1%FY 2018: -1201.5%FY 2019: -477200.0%FY 2020: -350020.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -8282.4%FY 2024: -3131.2%
FY 2015 5y median -3131.2% FY 2024
ROE 0.0%
FY 2015: -26.1%FY 2016: -26.0%FY 2017: -118.6%FY 2018: -67.3%FY 2019: -62.8%FY 2020: -56.5%FY 2021: -60.8%FY 2022: -948.2%FY 2023: -134.0%FY 2024: 0.0%
FY 2015 5y median -60.8% FY 2024
ROIC 0.0%
FY 2015: -20.0%FY 2016: -20.0%FY 2017: -75.2%FY 2018: -44.7%FY 2019: -36.4%FY 2020: -30.7%FY 2021: -39.4%FY 2022: -433.4%FY 2023: -61.2%FY 2024: 0.0%
FY 2015 5y median -39.4% FY 2024
ROA 0.0%
FY 2015: -18.3%FY 2016: -17.0%FY 2017: -72.6%FY 2018: -39.7%FY 2019: -31.9%FY 2020: -26.5%FY 2021: -33.2%FY 2022: -207.6%FY 2023: -51.9%FY 2024: 0.0%
FY 2015 5y median -33.2% FY 2024

Growth (YoY)

Revenue 82.4%
FY 2015: -97.9%FY 2016: 333633.3%FY 2017: -64.6%FY 2018: -12.0%FY 2019: -99.8%FY 2020: -16.7%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 82.4%
FY 2015 FY 2024
Operating Income 30.7%
FY 2015: -80.5%FY 2016: 13.7%FY 2017: -106.5%FY 2018: 27.8%FY 2019: 24.3%FY 2020: 41.2%FY 2021: -55.4%FY 2022: -54.8%FY 2023: 79.3%FY 2024: 30.7%
FY 2015 FY 2024
EPS (diluted) 57.6%
FY 2015: -40.6%FY 2016: 26.2%FY 2017: -131.6%FY 2018: 44.4%FY 2019: 29.8%FY 2020: 45.0%FY 2021: -34.9%FY 2022: -6.5%FY 2023: 81.8%FY 2024: 57.6%
FY 2015 FY 2024
Free Cash Flow 0.0%
FY 2015: -55.9%FY 2016: 5.9%FY 2017: -90.4%FY 2018: 42.4%FY 2019: 0.7%FY 2020: 2.9%FY 2021: 3.4%FY 2022: -4.1%FY 2023: 42.8%FY 2024: 0.0%
FY 2015 FY 2024

Financial Health

Current Ratio 0.0×
FY 2015: 9.5×FY 2016: 7.6×FY 2017: 4.6×FY 2018: 5.4×FY 2019: 3.6×FY 2020: 1.7×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 3.8×FY 2024: 0.0×
FY 2015 5y median 1.7× FY 2024
Quick Ratio 0.0×
FY 2015: 9.5×FY 2016: 7.5×FY 2017: 4.6×FY 2018: 5.4×FY 2019: 3.6×FY 2020: 1.5×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 3.8×FY 2024: 0.0×
FY 2015 5y median 1.5× FY 2024
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.0×
FY 2015 5y median 0.1× FY 2024
Net Debt / EBITDA 0.0×
FY 2015: 3.5×FY 2016: 2.1×FY 2017: 0.5×FY 2018: 1.1×FY 2019: 1.3×FY 2020: 0.9×FY 2021: 1.1×FY 2022: 0.3×FY 2023: 0.8×FY 2024: 0.0×
FY 2015 5y median 0.8× FY 2024
Interest Coverage 0.0×
FY 2015: -126×FY 2016: -235×FY 2017: -367×FY 2018: -616×FY 2019: -84.2×FY 2020: -39.1×FY 2021: -103×FY 2022: -207×FY 2023: -101×FY 2024: 0.0×
FY 2015 5y median -101× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31